Healthcare AI is advancing faster than the rules that govern it, and experts warn that without clear governance and public trust, the technology risks being rejected by patients and providers alike. At a panel discussion hosted by Florida International University (FIU) in Washington, D.C., federal and academic research leaders outlined why establishing transparent "rules of the road" for artificial intelligence in medicine is now as important as the technology itself .

What's Holding Back Healthcare AI Adoption?

The conversation revealed a paradox: AI is already delivering measurable results in clinical diagnosis, yet many patients and healthcare providers remain skeptical. The core issue isn't technical capability, but trust. Without confidence in how AI tools work and who oversees them, even proven technologies struggle to gain acceptance in hospitals and clinics .

"If there isn't trust in the tool, then you can't necessarily trust there won't be bias," said Sunita Krishnan, senior program officer at the National Academy of Medicine.

Sunita Krishnan, Senior Program Officer at the National Academy of Medicine

Krishnan emphasized that trust frameworks must go beyond technical validation. They require proper education and training for healthcare professionals, coordinated policy approaches across states and federal agencies, and transparency with patients about when and how AI is being used in their care .

Where Is AI Already Making a Difference in Cancer Care?

Despite governance challenges, AI is already proving its value in specific clinical applications. The National Cancer Institute (NCI) is seeing early success with AI in procedural and administrative tasks, while clinical diagnosis applications have shown promise in detecting liver and prostate cancers . These wins demonstrate that AI isn't a distant future technology; it's already in use today.

Sylvia Shabaya Gayle, scientific program director for bioinformatics and computational science at the National Cancer Institute, highlighted these successes while stressing a critical safeguard: human validation remains essential. "We still have to keep a human in the loop," Gayle explained, noting that AI tools must be validated by trained professionals to ensure accuracy and protect patient care .

This human-centered approach reflects a broader consensus among the panelists. Rather than replacing doctors, effective healthcare AI augments clinical decision-making by handling data analysis and pattern recognition while leaving final medical judgments to qualified professionals.

How to Build Responsible AI Healthcare Systems

• Establish Clear Regulatory Frameworks: The United States needs defined governance structures that allow AI to scale responsibly while maintaining safety standards, similar to how the FDA regulates pharmaceuticals and medical devices.
• Maintain Human Oversight in Decision-Making: AI should support clinical decisions, not replace them. Trained healthcare professionals must validate AI recommendations and retain authority over patient care choices.
• Create Transparency Mechanisms: Patients deserve to know when AI is involved in their diagnosis or treatment planning, and healthcare systems must communicate clearly about how these tools work and their limitations.
• Develop Coordinated Policy Approaches: Fragmented AI policies across states and agencies create confusion. National coordination ensures consistent standards while allowing for regional flexibility.
• Invest in Education and Training: Healthcare professionals need ongoing education about AI capabilities, limitations, and ethical use to effectively integrate these tools into clinical practice.

The National Academy of Medicine, chartered by Abraham Lincoln and one of the nation's oldest institutions, is positioning itself as a "North Star" in developing systems that advance health and science responsibly . This institutional commitment signals that governance isn't an afterthought to AI development; it's foundational.

Why Universities Are Stepping Into the AI Healthcare Gap

Universities are emerging as crucial bridges between cutting-edge research and responsible implementation. Diana Azzam, associate professor in the Robert Stempel College of Public Health and Social Work at FIU, is leading innovative precision medicine research on pediatric cancer patients using AI . Her work exemplifies how academic institutions can advance AI healthcare while maintaining rigorous ethical standards.

FIU's commitment extends beyond research. The university is preparing the next generation of healthcare leaders who understand both the promise and complexity of AI as an emerging technology. More than 20 students participated in FIU's "Future of Artificial Intelligence" Fly-In program in Washington, D.C., engaging directly with national policymakers and research leaders . This educational focus suggests that the future of healthcare AI depends on training professionals who can navigate both technical and ethical dimensions of the technology.

The panel discussion underscored an important reality: healthcare AI's success won't be determined by how sophisticated the algorithms become, but by whether patients, providers, and policymakers trust the systems guiding clinical decisions. As AI moves from research labs into hospitals and clinics, building that trust through transparent governance, human oversight, and coordinated policy has become as critical as the technology itself.